GXP PHARMAID ApS: Financial statements 2014
CVR: 29615861
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
GXP PHARMAID ApS (CVR 29615861) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 3,604,083 and a net result of DKK 380,379 compared with DKK 450,698 the year before. That is an increase of 56.3% compared with the year before. Equity in the 2014 report amounted to DKK 1,114,147. The solvency ratio was 43.6%.
- Gross Profit
- DKK 3,604,083
- Profit/Loss
- DKK 380,379
- Equity
- DKK 1,114,147
- Total Assets
- DKK 2,555,211
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 3.6 mio. | 380 t. | 1.1 mio. | - |
| 2013 | - | 2.3 mio. | 451 t. | 1.1 mio. | - |
| 2012 | - | 2.1 mio. | - | - | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of August 12, 2014, Nusret Asanovski has left the board of directors of GXP PHARMAID ApS.
As of August 12, 2014, Jonas Evjenios Markou has left the board of directors of GXP PHARMAID ApS.
As of August 12, 2014, Mogens Birch-Larsen has left the board of directors of GXP PHARMAID ApS.
GXP PHARMAID ApS has published its annual report for 2013. Gross profit came to DKK 2,306,234, and the net result was DKK 450,698.
About GXP PHARMAID ApS
GXP PHARMAID ApS is a Danish company of the type Anpartsselskab based in Brønshøj, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The company was previously named Q-VIGILANCE ApS. The management consists of Nusret Asanovski. The company is owned by MAC ANDORBY ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,163,256 and a net result of DKK 122,320 compared with DKK 216,532 the year before. Equity in the 2025 report amounted to DKK 1,218,531.